Insider
| Ticker | Insider | Role | Type | Date | Shares | Price | Value | Notes | Filing |
|---|---|---|---|---|---|---|---|---|---|
| DGX | Davis J. E. | CEO and President | Sale | 2026-09-01 | 10,000 | $242.72 | $2,427,200 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Option exercise | 2026-08-28 | 22,677 | $112.17 | $2,543,679 | Acquired | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2026-08-28 | 16,010 | $242.88 | $3,888,437 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2026-08-28 | 6,237 | $243.63 | $1,519,505 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2026-08-28 | 430 | $244.51 | $105,141 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Gift | 2026-08-28 | 1,000 | — | — | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Sale | 2026-07-28 | 1,600 | $235.18 | $376,288 | Disposed | EDGAR |
| DGX | CARTER ROBERT B | Director | L | 2026-07-22 | 11 | $206.80 | $2,275 | Acquired | EDGAR |
| DGX | Lassiter Wright III | Director | L | 2026-07-22 | 6 | $206.81 | $1,241 | Acquired | EDGAR |
| DGX | Gregg Vicky B | Director | Award | 2026-07-22 | 72 | $206.81 | $14,890 | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | L | 2026-07-22 | 34 | $206.81 | $7,031 | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | L | 2026-07-22 | 46 | $206.81 | $9,513 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L | 2026-07-22 | 37 | $206.81 | $7,652 | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Award | 2026-07-22 | 102 | $206.81 | $21,094 | Acquired | EDGAR |
| DGX | MAIN TIMOTHY L | Director | L | 2026-07-22 | 21 | $206.81 | $4,343 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Option exercise | 2026-06-04 | 3,320 | $127.72 | $424,047 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Option exercise | 2026-06-04 | 4,827 | $121.81 | $587,953 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sale | 2026-06-04 | 8,147 | $200.00 | $1,629,400 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2026-06-01 | 10,000 | $194.14 | $1,941,400 | Disposed | EDGAR |
| DGX | CARTER ROBERT B | Director | Award | 2026-05-20 | 1,142 | — | — | Acquired | EDGAR |
| DGX | Gregg Vicky B | Director | Award | 2026-05-20 | 1,142 | — | — | Acquired | EDGAR |
| DGX | Diaz Luis | Director | Award | 2026-05-20 | 1,142 | — | — | Acquired | EDGAR |
| DGX | RING TIMOTHY M | Director | Award | 2026-05-20 | 1,142 | — | — | Acquired | EDGAR |
| DGX | Doi Tracey | Director | Award | 2026-05-20 | 1,142 | — | — | Acquired | EDGAR |
| DGX | WENTWORTH TIMOTHY C | Director | Award | 2026-05-20 | 1,142 | — | — | Acquired | EDGAR |
| DGX | PFEIFFER GARY M | Director | Award | 2026-05-20 | 1,142 | — | — | Acquired | EDGAR |
| DGX | Lassiter Wright III | Director | Award | 2026-05-20 | 1,142 | — | — | Acquired | EDGAR |
| DGX | MAIN TIMOTHY L | Director | Award | 2026-05-20 | 1,142 | — | — | Acquired | EDGAR |
| DGX | MORRISON DENISE M | Director | Award | 2026-05-20 | 1,142 | — | — | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | L | 2026-04-20 | 49 | $194.70 | $9,540 | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | L | 2026-04-20 | 37 | $194.70 | $7,204 | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Award | 2026-04-20 | 108 | $194.70 | $21,027 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L | 2026-04-20 | 39 | $194.70 | $7,593 | Acquired | EDGAR |
| DGX | Lassiter Wright III | Director | L | 2026-04-20 | 6 | $194.70 | $1,168 | Acquired | EDGAR |
| DGX | Gregg Vicky B | Director | Award | 2026-04-20 | 68 | $194.70 | $13,239 | Acquired | EDGAR |
| DGX | CARTER ROBERT B | Director | L | 2026-04-20 | 7 | $194.70 | $1,363 | Acquired | EDGAR |
| DGX | WENTWORTH TIMOTHY C | Director | Award | 2026-03-09 | 215 | — | — | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Sale | 2026-03-05 | 2,855 | $206.21 | $588,730 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2026-03-05 | 3,878 | $206.21 | $799,682 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2026-03-05 | 5,558 | $206.21 | $1,146,115 | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Award | 2026-03-04 | 5,682 | $204.86 | $1,164,015 | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Tax withholding | 2026-03-04 | 2,326 | $204.86 | $476,504 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Award | 2026-03-04 | 6,200 | $204.86 | $1,270,132 | Acquired | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Award | 2026-03-04 | 11,364 | $204.86 | $2,328,029 | Acquired | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Tax withholding | 2026-03-04 | 5,806 | $204.86 | $1,189,417 | Disposed | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Award | 2026-03-04 | 13,947 | $204.86 | $2,857,182 | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Tax withholding | 2026-03-04 | 7,720 | $204.86 | $1,581,519 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Award | 2026-03-04 | 5,682 | $204.86 | $1,164,015 | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Tax withholding | 2026-03-04 | 2,827 | $204.86 | $579,139 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Award | 2026-03-04 | 7,232 | $204.86 | $1,481,548 | Acquired | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Tax withholding | 2026-03-04 | 3,354 | $204.86 | $687,100 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Award | 2026-03-04 | 51,652 | $204.86 | $10,581,429 | Acquired | EDGAR |
| DGX | Davis J. E. | CEO and President | Tax withholding | 2026-03-04 | 26,414 | $204.86 | $5,411,172 | Disposed | EDGAR |
| DGX | Deppe Michael J | SVP, Corp. Controller & CAO | Award | 2026-03-04 | 1,473 | $204.86 | $301,759 | Acquired | EDGAR |
| DGX | Deppe Michael J | SVP, Corp. Controller & CAO | Tax withholding | 2026-03-04 | 750 | $204.86 | $153,645 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sale | 2026-03-04 | 2,628 | $204.86 | $538,372 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2026-03-03 | 526 | $207.73 | $109,266 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2026-03-03 | 632 | $207.73 | $131,285 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Sale | 2026-03-03 | 410 | $207.73 | $85,169 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Tax withholding | 2026-03-02 | 288 | $204.86 | $59,000 | Disposed | EDGAR |
| DGX | Deppe Michael J | SVP, Corp. Controller & CAO | Tax withholding | 2026-03-02 | 88 | $204.86 | $18,028 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Tax withholding | 2026-03-02 | 648 | $204.86 | $132,749 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Tax withholding | 2026-03-02 | 205 | $204.86 | $41,996 | Disposed | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Tax withholding | 2026-03-02 | 869 | $204.86 | $178,023 | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Tax withholding | 2026-03-02 | 188 | $204.86 | $38,514 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Tax withholding | 2026-03-02 | 2,968 | $204.86 | $608,024 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2026-03-02 | 10,000 | $212.52 | $2,125,200 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Tax withholding | 2026-03-02 | 230 | $204.86 | $47,118 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2026-02-19 | 1,433 | $204.83 | $293,521 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2026-02-19 | 1,111 | $204.83 | $227,566 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Sale | 2026-02-19 | 958 | $204.83 | $196,227 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Award | 2026-02-18 | 2,928 | — | — | Acquired | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Tax withholding | 2026-02-18 | 433 | $210.01 | $90,934 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Tax withholding | 2026-02-18 | 728 | $206.99 | $150,689 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Award | 2026-02-18 | 2,013 | — | — | Acquired | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Tax withholding | 2026-02-18 | 301 | $210.01 | $63,213 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Tax withholding | 2026-02-18 | 347 | $206.99 | $71,826 | Disposed | EDGAR |
| DGX | Deppe Michael J | SVP, Corp. Controller & CAO | Award | 2026-02-18 | 366 | — | — | Acquired | EDGAR |
| DGX | Deppe Michael J | SVP, Corp. Controller & CAO | Tax withholding | 2026-02-18 | 83 | $210.01 | $17,431 | Disposed | EDGAR |
| DGX | Deppe Michael J | SVP, Corp. Controller & CAO | Tax withholding | 2026-02-18 | 99 | $206.99 | $20,492 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Award | 2026-02-18 | 15,857 | — | — | Acquired | EDGAR |
| DGX | Davis J. E. | CEO and President | Tax withholding | 2026-02-18 | 2,396 | $210.01 | $503,184 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Tax withholding | 2026-02-18 | 3,788 | $206.99 | $784,078 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Award | 2026-02-18 | 1,952 | — | — | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Tax withholding | 2026-02-18 | 244 | $210.01 | $51,242 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Tax withholding | 2026-02-18 | 293 | $206.99 | $60,648 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Tax withholding | 2026-02-18 | 252 | $210.01 | $52,923 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Tax withholding | 2026-02-18 | 259 | $206.99 | $53,610 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Award | 2026-02-18 | 2,135 | — | — | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Award | 2026-02-18 | 3,965 | — | — | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Tax withholding | 2026-02-18 | 855 | $210.01 | $179,559 | Disposed | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Tax withholding | 2026-02-18 | 1,010 | $206.99 | $209,060 | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Award | 2026-02-18 | 1,586 | — | — | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Tax withholding | 2026-02-18 | 205 | $210.01 | $43,052 | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Tax withholding | 2026-02-18 | 230 | $206.99 | $47,608 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Option exercise | 2026-02-13 | 26,165 | $112.17 | $2,934,928 | Acquired | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2026-02-13 | 10,573 | $205.21 | $2,169,656 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2026-02-13 | 10,122 | $206.37 | $2,088,883 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2026-02-13 | 3,500 | $207.08 | $724,788 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2026-02-13 | 1,619 | $208.21 | $337,093 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2026-02-13 | 351 | $209.10 | $73,395 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Option exercise | 2026-02-10 | 5,662 | $121.81 | $689,660 | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Sale | 2026-02-10 | 5,662 | $204.00 | $1,155,048 | Disposed | EDGAR |
| DGX | CARTER ROBERT B | Director | L | 2026-01-28 | 6 | $183.51 | $1,101 | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Award | 2026-01-28 | 48 | $183.51 | $8,809 | Acquired | EDGAR |
| DGX | Lassiter Wright III | Director | L | 2026-01-28 | 7 | $183.51 | $1,285 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L | 2026-01-28 | 16 | $183.52 | $2,936 | Acquired | EDGAR |
| DGX | Gregg Vicky B | Director | L | 2026-01-28 | 67 | $183.51 | $12,295 | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Award | 2026-01-28 | 69 | $183.51 | $12,662 | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | L | 2026-01-28 | 15 | $183.51 | $2,753 | Acquired | EDGAR |
| DGX | Gregg Vicky B | Director | Sale | 2025-11-25 | 1,250 | $191.76 | $239,700 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Option exercise | 2025-11-25 | 55,093 | $95.80 | $5,277,634 | Acquired | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-11-25 | 9,342 | $191.59 | $1,789,823 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-11-25 | 41,004 | $192.27 | $7,883,901 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-11-25 | 4,747 | $192.97 | $916,037 | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Option exercise | 2025-11-18 | 7,846 | $144.47 | $1,133,512 | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Option exercise | 2025-11-18 | 100 | $143.33 | $14,333 | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Sale | 2025-11-18 | 7,946 | $187.35 | $1,488,683 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Tax withholding | 2025-11-05 | 7,143 | $175.57 | $1,254,097 | Disposed | EDGAR |
| DGX | PFEIFFER GARY M | Director | Sale | 2025-10-22 | 1,482 | $182.40 | $270,317 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Award | 2025-10-21 | 15 | $189.08 | $2,836 | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Award | 2025-10-21 | 68 | $189.08 | $12,858 | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Award | 2025-10-21 | 15 | $189.08 | $2,836 | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Award | 2025-10-21 | 46 | $189.08 | $8,698 | Acquired | EDGAR |
| DGX | CARTER ROBERT B | Director | Award | 2025-10-21 | 6 | $189.09 | $1,135 | Acquired | EDGAR |
| DGX | Gregg Vicky B | Director | Award | 2025-10-21 | 70 | $189.08 | $13,236 | Acquired | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Option exercise | 2025-09-26 | 227 | $103.57 | $23,510 | Acquired | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2025-09-26 | 83 | $187.22 | $15,539 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2025-09-26 | 144 | $188.66 | $27,167 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Option exercise | 2025-09-24 | 175 | $103.57 | $18,125 | Acquired | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2025-09-24 | 175 | $187.02 | $32,729 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Option exercise | 2025-09-23 | 28,288 | $103.57 | $2,929,788 | Acquired | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2025-09-23 | 28,288 | $187.12 | $5,293,313 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Sale | 2025-08-21 | 1,975 | $185.00 | $365,375 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Option exercise | 2025-08-19 | 4,532 | $112.17 | $508,354 | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Sale | 2025-08-19 | 4,532 | $183.00 | $829,356 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Sale | 2025-08-15 | 1,975 | $180.00 | $355,500 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Tax withholding | 2025-08-13 | 123 | $175.91 | $21,637 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Option exercise | 2025-08-06 | 3,560 | $86.63 | $308,403 | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Sale | 2025-08-06 | 3,560 | $175.00 | $623,000 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Sale | 2025-08-06 | 1,975 | $175.00 | $345,625 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sale | 2025-07-31 | 2,210 | $170.00 | $375,700 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Option exercise | 2025-07-30 | 3,045 | $86.63 | $263,788 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sale | 2025-07-30 | 3,045 | $167.40 | $509,733 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Option exercise | 2025-07-30 | 5,224 | $112.17 | $585,976 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sale | 2025-07-30 | 5,224 | $167.40 | $874,498 | Disposed | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | L | 2025-07-21 | 72 | $167.50 | $12,060 | Acquired | EDGAR |
| DGX | Lassiter Wright III | Director | L | 2025-07-21 | 7 | $167.50 | $1,173 | Acquired | EDGAR |
| DGX | Gregg Vicky B | Director | L | 2025-07-21 | 79 | $167.50 | $13,232 | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | L | 2025-07-21 | 80 | $167.49 | $13,400 | Acquired | EDGAR |
| DGX | CARTER ROBERT B | Director | L | 2025-07-21 | 7 | $167.50 | $1,173 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L | 2025-07-21 | 27 | $167.50 | $4,522 | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | L | 2025-07-21 | 17 | $167.49 | $2,847 | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Tax withholding | 2025-07-16 | 850 | $169.01 | $143,658 | Disposed | EDGAR |
| DGX | PFEIFFER GARY M | Director | Award | 2025-05-15 | 1,203 | — | — | Acquired | EDGAR |
| DGX | Doi Tracey | Director | Award | 2025-05-15 | 1,203 | — | — | Acquired | EDGAR |
| DGX | MAIN TIMOTHY L | Director | Award | 2025-05-15 | 1,203 | — | — | Acquired | EDGAR |
| DGX | Diaz Luis | Director | Award | 2025-05-15 | 1,203 | — | — | Acquired | EDGAR |
| DGX | Lassiter Wright III | Director | Award | 2025-05-15 | 1,203 | — | — | Acquired | EDGAR |
| DGX | Gregg Vicky B | Director | Award | 2025-05-15 | 1,203 | — | — | Acquired | EDGAR |
| DGX | RING TIMOTHY M | Director | Award | 2025-05-15 | 1,203 | — | — | Acquired | EDGAR |
| DGX | CARTER ROBERT B | Director | Award | 2025-05-15 | 1,203 | — | — | Acquired | EDGAR |
| DGX | MORRISON DENISE M | Director | Award | 2025-05-15 | 1,203 | — | — | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Sale | 2025-05-13 | 874 | $175.31 | $153,221 | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Sale | 2025-05-12 | 874 | $175.72 | $153,579 | Disposed | EDGAR |
| DGX | Gregg Vicky B | Director | Award | 2025-04-21 | 68 | $164.42 | $11,181 | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | L | 2025-04-21 | 25 | $164.42 | $4,111 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L | 2025-04-21 | 27 | $164.42 | $4,439 | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | L | 2025-04-21 | 81 | $164.42 | $13,318 | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | L | 2025-04-21 | 74 | $164.42 | $12,167 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sale | 2025-04-02 | 2,555 | $170.00 | $434,350 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 2,366 | $168.03 | $397,553 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 1,411 | $168.76 | $238,114 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 704 | $169.63 | $119,416 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 7,249 | $167.86 | $1,216,845 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 4,905 | $168.72 | $827,564 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 2,764 | $169.56 | $468,662 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 6,950 | $167.86 | $1,166,627 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 5,900 | $168.66 | $995,121 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 2,493 | $169.57 | $422,736 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 750 | $167.86 | $125,897 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 584 | $168.70 | $98,520 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 267 | $169.60 | $45,282 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 1,493 | $167.88 | $250,643 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 902 | $168.79 | $152,249 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Sale | 2025-04-02 | 453 | $169.63 | $76,844 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Tax withholding | 2025-03-26 | 162 | $166.71 | $27,007 | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Tax withholding | 2025-03-26 | 256 | $166.71 | $42,678 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2025-03-17 | 4,643 | $170.00 | $789,310 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2025-03-05 | 5,370 | $174.13 | $935,078 | Disposed | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Award | 2025-03-04 | 1,711 | $173.74 | $297,269 | Acquired | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2025-03-04 | 716 | $175.79 | $125,866 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Award | 2025-03-04 | 10,380 | $173.74 | $1,803,421 | Acquired | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Tax withholding | 2025-03-04 | 5,010 | $173.74 | $870,437 | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Award | 2025-03-04 | 5,317 | $173.74 | $923,776 | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Tax withholding | 2025-03-04 | 1,823 | $173.74 | $316,728 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Award | 2025-03-04 | 4,434 | $173.74 | $770,363 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Tax withholding | 2025-03-04 | 1,879 | $173.74 | $326,457 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Award | 2025-03-04 | 5,674 | $173.74 | $985,801 | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Tax withholding | 2025-03-04 | 2,280 | $173.74 | $396,127 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Award | 2025-03-04 | 61,917 | $173.74 | $10,757,460 | Acquired | EDGAR |
| DGX | Davis J. E. | CEO and President | Tax withholding | 2025-03-04 | 31,656 | $173.74 | $5,499,913 | Disposed | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Award | 2025-03-04 | 13,884 | $173.74 | $2,412,206 | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Tax withholding | 2025-03-04 | 7,684 | $173.74 | $1,335,018 | Disposed | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Tax withholding | 2025-03-04 | 867 | $173.74 | $150,633 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2025-03-04 | 592 | $175.79 | $104,068 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Award | 2025-03-04 | 8,549 | $173.74 | $1,485,303 | Acquired | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Tax withholding | 2025-03-04 | 3,906 | $173.74 | $678,628 | Disposed | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Tax withholding | 2025-03-03 | 1,692 | $173.74 | $293,968 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Tax withholding | 2025-03-03 | 394 | $173.74 | $68,454 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Tax withholding | 2025-03-03 | 992 | $173.74 | $172,350 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Tax withholding | 2025-03-03 | 106 | $173.74 | $18,416 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Tax withholding | 2025-03-03 | 1,662 | $173.74 | $288,756 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Tax withholding | 2025-03-03 | 322 | $173.74 | $55,944 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2025-02-27 | 824 | $172.61 | $142,231 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2025-02-27 | 528 | $172.61 | $91,138 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Tax withholding | 2025-02-26 | 229 | $171.75 | $39,331 | Disposed | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Tax withholding | 2025-02-26 | 869 | $171.75 | $149,251 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Tax withholding | 2025-02-26 | 455 | $171.75 | $78,146 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Tax withholding | 2025-02-26 | 2,966 | $171.75 | $509,410 | Disposed | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Tax withholding | 2025-02-26 | 88 | $171.75 | $15,114 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Tax withholding | 2025-02-26 | 233 | $171.75 | $40,018 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Tax withholding | 2025-02-26 | 286 | $171.75 | $49,120 | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Tax withholding | 2025-02-26 | 214 | $171.75 | $36,754 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2025-02-20 | 604 | $170.99 | $103,278 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2025-02-20 | 899 | $170.99 | $153,720 | Disposed | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Tax withholding | 2025-02-19 | 1,031 | $169.71 | $174,971 | Disposed | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Tax withholding | 2025-02-19 | 99 | $169.71 | $16,801 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Sale | 2025-02-19 | 320 | $169.71 | $54,307 | Disposed | EDGAR |
| DGX | Davis J. E. | CEO and President | Tax withholding | 2025-02-19 | 2,936 | $169.71 | $498,269 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Tax withholding | 2025-02-19 | 287 | $169.71 | $48,707 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Tax withholding | 2025-02-19 | 374 | $169.71 | $63,472 | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Tax withholding | 2025-02-19 | 242 | $169.71 | $41,070 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2025-02-19 | 535 | $169.71 | $90,795 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Award | 2025-02-12 | 2,269 | — | — | Acquired | EDGAR |
| DGX | Davis J. E. | CEO and President | Award | 2025-02-12 | 18,149 | — | — | Acquired | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Award | 2025-02-12 | 3,479 | — | — | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | Award | 2025-02-12 | 2,042 | — | — | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | Award | 2025-02-12 | 4,538 | — | — | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Award | 2025-02-12 | 1,815 | — | — | Acquired | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Award | 2025-02-12 | 2,345 | — | — | Acquired | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Award | 2025-02-12 | 454 | — | — | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | Sale | 2025-02-05 | 403 | $164.30 | $66,214 | Disposed | EDGAR |
| DGX | Gregg Vicky B | Director | Sale | 2025-02-05 | 1,250 | $164.57 | $205,710 | Disposed | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | L | 2025-01-29 | 4 | $158.03 | $632 | Acquired | EDGAR |
| DGX | Gregg Vicky B | Director | L | 2025-01-29 | 72 | $158.04 | $11,379 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L | 2025-01-29 | 12 | $158.03 | $1,896 | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | L | 2025-01-29 | 35 | $158.04 | $5,531 | Acquired | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | L | 2025-01-29 | 57 | $158.04 | $9,008 | Acquired | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Option exercise | 2024-11-29 | 35,146 | $86.63 | $3,044,698 | Acquired | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2024-11-29 | 3,009 | $162.26 | $488,237 | Disposed | EDGAR |
| DGX | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale | 2024-11-29 | 32,137 | $163.15 | $5,243,065 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Option exercise | 2024-11-27 | 33,103 | $103.57 | $3,428,478 | Acquired | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2024-11-27 | 4,803 | $162.14 | $778,775 | Disposed | EDGAR |
| DGX | Doherty Catherine T. | EVP, Regional Businesses | Sale | 2024-11-27 | 28,300 | $163.13 | $4,616,709 | Disposed | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Option exercise | 2024-11-06 | 8,635 | $71.17 | $614,553 | Acquired | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Option exercise | 2024-11-06 | 10,120 | $66.51 | $673,081 | Acquired | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sale | 2024-11-06 | 2,100 | $152.70 | $320,676 | Disposed | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sale | 2024-11-06 | 2,400 | $153.98 | $369,559 | Disposed | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sale | 2024-11-06 | 4,135 | $154.74 | $639,833 | Disposed | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sale | 2024-11-06 | 2,600 | $152.71 | $397,050 | Disposed | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sale | 2024-11-06 | 2,331 | $154.03 | $359,046 | Disposed | EDGAR |
| DGX | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sale | 2024-11-06 | 5,189 | $154.74 | $802,958 | Disposed | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sale | 2024-10-28 | 1,775 | $156.92 | $278,525 | Disposed | EDGAR |
| DGX | Plewman Patrick | SVP for Diagnostic Services | L | 2024-10-21 | 60 | $149.37 | $8,962 | Acquired | EDGAR |
| DGX | SAMAD SAM | Executive Vice President & CFO | L | 2024-10-21 | 37 | $149.37 | $5,527 | Acquired | EDGAR |
| DGX | Gregg Vicky B | Director | L | 2024-10-21 | 76 | $149.37 | $11,352 | Acquired | EDGAR |
| DGX | DELANEY MARK E | SVP & Chief Commercial Officer | L | 2024-10-21 | 4 | $149.39 | $598 | Acquired | EDGAR |
| DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L | 2024-10-21 | 21 | $149.37 | $3,137 | Acquired | EDGAR |
| DGX | GARDNER MARK A | SVP of Molecular Gen & Oncol | Tax withholding | 2024-09-24 | 120 | $155.70 | $18,684 | Disposed | EDGAR |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status